[PDF] journalagent.com

[PDF][PDF] A review of the fixed dose use of new oral anticoagulants in obese patients: Is it really enough?

E Güler, GB Güler, GG Demir… - The Anatolian Journal …, 2015 - jag.journalagent.com
Obesity is a significant cause of morbidity and mortality, and it is becoming increasingly
prevalent worldwide. Altered pharmacodynamics and pharmacokinetics of drugs in obese …
被引用次数：32 相关文章
[HTML] nih.gov

[HTML][HTML] A review of the fixed dose use of new oral anticoagulants in obese patients: Is it really enough?

E Güler, GB Güler, GG Demir… - Anatolian Journal of …, 2016 - ncbi.nlm.nih.gov
Obesity is a significant cause of morbidity and mortality, and it is becoming increasingly
prevalent worldwide. Altered pharmacodynamics and pharmacokinetics of drugs in obese …

A review of the fixed dose use of new oral anticoagulants in obese patients: Is it really enough?

E Güler, GB Güler, GG Demir… - The Anatolian Journal of …, 2015 - search.proquest.com
Obesity is a significant cause of morbidity and mortality, and it is becoming increasingly
prevalent worldwide. Altered pharmacodynamics and pharmacokinetics of drugs in obese …

A review of the fixed dose use of new oral anticoagulants in obese patients: Is it really enough?

E Güler, GG Demir, S Hatipoğlu - Anatolian Journal of Cardiology, 2015 - europepmc.org
Obesity is a significant cause of morbidity and mortality, and it is becoming increasingly
prevalent worldwide. Altered pharmacodynamics and pharmacokinetics of drugs in obese …

A review of the fixed dose use of new oral anticoagulants in obese patients: Is it really enough?

E Güler, GB Güler, GG Demir… - Anatolian journal of …, 2015 - pubmed.ncbi.nlm.nih.gov
Obesity is a significant cause of morbidity and mortality, and it is becoming increasingly
prevalent worldwide. Altered pharmacodynamics and pharmacokinetics of drugs in obese …
[PDF] journalagent.com

[PDF][PDF] A review of the fixed dose use of new oral anticoagulants in obese patients: Is it really enough?

E Güler, GB Güler, GG Demir, S Hatipoğlu - 2015 - jag.journalagent.com
Obesity is a significant cause of morbidity and mortality, and it is becoming increasingly
prevalent worldwide. Altered pharmacodynamics and pharmacokinetics of drugs in obese …

A review of the fixed dose use of new oral anticoagulants in obese patients: Is it really enough?

E Güler, GB Güler, GG Demir… - The Anatolian Journal …, 2015 - acikerisim.medipol.edu.tr
Obesity is a significant cause of morbidity and mortality, and it is becoming increasingly
prevalent worldwide. Altered pharmacodynamics and pharmacokinetics of drugs in obese …
[PDF] researchgate.net

[PDF][PDF] A review of the fixed dose use of new oral anticoagulants in obese patients: Is it really enough?

E Güler, GB Güler, GG Demir, S Hatipoğlu - 2015 - researchgate.net
Obesity is a significant cause of morbidity and mortality, and it is becoming increasingly
prevalent worldwide. Altered pharmacodynamics and pharmacokinetics of drugs in obese …
[PDF] academia.edu

[PDF][PDF] A review of the fixed dose use of new oral anticoagulants in obese patients: Is it really enough?

E Güler, GB Güler, GG Demir, S Hatipoğlu - 2015 - academia.edu
Obesity is a significant cause of morbidity and mortality, and it is becoming increasingly
prevalent worldwide. Altered pharmacodynamics and pharmacokinetics of drugs in obese …

review of the fixed dose use of new oral anticoagulants in obese patients: Is it really enough?

E Güler, GB Güler, GG Demir… - Anatolian Journal of …, 2015 - search.ebscohost.com
Obesity is a significant cause of morbidity and mortality, and it is becoming increasingly
prevalent worldwide. Altered pharmacodynamics and pharmacokinetics of drugs in obese …